Search the Newsreel

How Investors Are Reacting To LeMaitre Vascular (LMAT) Slower Projected Revenue Growth And Mixed Earnings Track Record

Earnings call transcript: LeMaitre Vascular slips on Q2 2026 miss, cuts outlook

LeMaitre Vascular reported a Q2 2026 earnings and revenue miss, leading to a significant after-hours stock drop. Despite strong year-over-year growth and margin expansion, the company cut its full-year organic revenue growth outlook due to foreign exchange pressures, Middle East shipping delays, and cardiac …

LeMaitre says Artegraft is now approved in 56 countries

LeMaitre (NASDAQ: LMAT) reported strong Q2 2026 financial results with net sales up 10% year-over-year to $70.4 million and diluted EPS up 23% to $0.74. A key growth driver was Artegraft, whose sales increased by 34%, now representing 21% of total sales and approved …

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Microvast Holdings, Inc. (MVST)

Bernstein Liebhard LLP has announced a securities class action lawsuit against Microvast Holdings, Inc. (NASDAQ: MVST) on behalf of investors who purchased shares between April 1, 2025, and March 16, 2026. The lawsuit alleges that Microvast made false and misleading statements about its business, …

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Exploring a 14.61% Potential Upside in the Healthcare Sector

LeMaitre Vascular, Inc. (LMAT) is a significant player in the healthcare sector, specifically in medical instruments for vascular surgery, with a market capitalization of $2.37 billion. The company shows strong financial health with 11.20% revenue growth, a 16.55% return on equity, and a forward …

LeMaitre Vascular earnings on deck as margin gains test continues

LeMaitre Vascular is set to announce its second-quarter earnings, with investors closely watching its ability to maintain significant margin expansion and accelerate profit growth. Analysts anticipate earnings of $0.81 per share on revenue of $71.5 million, reflecting substantial year-over-year growth. The company's premium valuation …

LeMaitre Q2 2026 Financial Results

LeMaitre Vascular, Inc. reported strong Q2 2026 financial results with sales up 10% to $70.4 million and EPS up 23% to $0.74, driven by a 34% increase in Artegraft sales and operational efficiencies. The company announced a quarterly dividend of $0.25/share and provided optimistic …

LeMaitre: Q2 Earnings Snapshot

LeMaitre Vascular Inc. (LMAT) reported a second-quarter profit of $17.1 million, or 74 cents per share, on revenue of $70.4 million. The medical device maker anticipates revenue for the current quarter to be between $66.3 million and $68.3 million, with full-year earnings projected at …

Microvast Deadline Alert

Faruqi & Faruqi, LLP is investigating potential claims against Microvast Holdings, Inc. (NASDAQ: MVST) and reminds investors of the February 5, 2024 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit. The lawsuit alleges that Microvast made false …

Alto Ingredients And 2 Other Promising Penny Stocks

This article identifies Alto Ingredients, Microvast Holdings, and Rocket Pharmaceuticals as promising penny stocks, highlighting their financial health and growth potential. It discusses Alto Ingredients' recent index additions and financial turnaround, Microvast's challenges despite debt reduction, and Rocket Pharmaceuticals' pre-revenue status and market volatility. …

LeMaitre Vascular, Inc. $LMAT Shares Sold by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC reduced its stake in LeMaitre Vascular, Inc. (LMAT) by 34.9% in the first quarter, selling 27,990 shares and retaining 52,252 shares valued at approximately $5.7 million. The medical instruments supplier reported strong Q1 earnings, beating estimates with $0.68 EPS …

LeMaitre (NASDAQ:LMAT) Misses Q2 CY2026 Revenue Estimates, Stock Drops 11.6%

LeMaitre (NASDAQ:LMAT) Misses Q2 CY2026 Revenue Estimates, Stock Drops 11.6% Medical device company LeMaitre Vascular (NASDAQ:LMAT) missed Wall Street's revenue expectations in Q2 CY2026, but sales rose 9.6% year on year to $70.38 million. Next quarter's revenue guidance of $67.3 million underwhelmed, coming in …

LeMaitre Vascular (NASDAQ:LMAT) Posts Earnings Results

LeMaitre Vascular (LMAT) Earnings Date and Reports 2026

Shareholders who lost money in shares of Microvast Holdings, Inc. (NASDAQ: MVST) Should Contact Wolf Haldenstein Immediately

Wolf Haldenstein Adler Freeman & Herz LLP has filed a securities fraud class action lawsuit against Microvast Holdings, Inc. (NASDAQ: MVST) on behalf of investors who purchased shares between April 1, 2025, and March 16, 2026, and suffered losses. The lawsuit alleges that Microvast …

Deadline Alert: Microvast Holdings, Inc. (MVST) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Glancy Prongay Wolke & Rotter LLP is urging shareholders of Microvast Holdings, Inc. (MVST) who incurred losses to contact the firm regarding a securities fraud lawsuit. The deadline to file as a lead plaintiff is September 21, 2026. The lawsuit alleges that Microvast made …

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Microvast Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MVST

The Rosen Law Firm is reminding investors who purchased Microvast Holdings, Inc. (NASDAQ: MVST) securities between April 1, 2025, and March 16, 2026, about the September 21, 2026, lead plaintiff deadline for a securities class action lawsuit. The lawsuit alleges that Microvast made materially …

Robbins LLP Reminds Microvast Investors With Significant Losses of the Opportunity to Lead the Securities Fraud Class Action Against MVST

Robbins LLP is reminding investors who suffered significant losses in Microvast Holdings, Inc. (NASDAQ: MVST) between April 1, 2025, and March 16, 2026, about their opportunity to lead a securities fraud class action. The lawsuit alleges that Microvast misled investors regarding its ability to …

Kaplan Fox Encourages Microvast Holdings, Inc. (MVST) Investors Seeking Recovery to Contact the Firm Before September 21, 2026

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Microvast Holdings, Inc. (MVST) on behalf of investors who purchased securities between April 1, 2025, and March 16, 2026. The lawsuit alleges that Microvast made false and misleading statements regarding its manufacturing …

Microvast (MVST) Expected to Post Quarterly Earnings on Monday

LeMaitre (LMAT) Reports Earnings Tomorrow: What To Expect

LeMaitre (LMAT) Reports Earnings Tomorrow: What To Expect Medical device company LeMaitre Vascular (NASDAQ:LMAT) will be announcing earnings results this Tuesday after market close. Here's what you need to know. LeMaitre met analysts' revenue expectations last quarter, reporting revenues of $66.55 million, up 11.2% …

LeMaitre Vascular (LMAT) Holds A 15% Undervalued View, Is The Stock Fully Priced?

LeMaitre Vascular (LMAT) closed at $101.32 on July 29, 2026, and is considered 15% undervalued with a fair value of $118.75 based on analyst forecasts and a strong product pipeline. However, its P/E ratio of 37.1x screens as expensive against the market and industry, …

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Average Rating of "Moderate Buy" by Brokerages

LeMaitre Vascular, Inc. (NASDAQ:LMAT) has received an average "Moderate Buy" rating from brokerages, with an average 12-month price target of $112.60. The company recently surpassed quarterly EPS expectations and saw an 11.1% revenue increase. Despite insider stock sales totaling approximately $5.9 million, institutional investors …

Price to book forward of Microvast Holdings, Inc. – NASDAQ:MVST

This article provides financial information for Microvast Holdings, Inc. (NASDAQ: MVST), specifically focusing on its "Price to book forward" metric. The content is presented within the context of a financial data platform, indicating it's a data point rather than an in-depth analysis. It highlights …

🏗️🏗️🏗️ Petroleira Azevedo Travassos - Azte3 🏗️🏗️🏗️ ( AZTE3

Precision Trading with Lemaitre Vascular Inc. (LMAT) Risk Zones

This article from Stock Traders Daily provides a detailed analysis of Lemaitre Vascular Inc. (LMAT) focusing on precision trading strategies and risk zones. It highlights near-term strong sentiment, mid-term neutrality, and long-term positive bias, along with specific entry, target, and stop-loss levels for different …

Sei Investments Co. Boosts Stock Holdings in LeMaitre Vascular, Inc. $LMAT

Sei Investments Co. increased its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 30.7% in the first quarter, now holding 136,674 shares valued at $14.92 million. Other

Securities Fraud Class Action Filed Against Microvast Holdings, Inc. (MVST) - Levi & Korsinsky Reminds Investors of September 21, 2026

Levi & Korsinsky, LLP has filed a securities class action lawsuit against Microvast Holdings, Inc. (MVST) on behalf of investors who suffered losses due to alleged securities fraud between April 1, 2025, and March 16, 2026. The lawsuit claims Microvast made false statements regarding …

Kaplan Fox Reminds Investors of Microvast Holdings, Inc. (NASDAQ: MVST) to a Securities Class Action Deadline - Contact the Firm Before September 21, 2026

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Microvast Holdings, Inc. (NASDAQ: MVST) on behalf of investors who purchased securities between April 1, 2025, and March 16, 2026. The lawsuit alleges Microvast made false and misleading statements regarding its production …

LeMaitre Vascular Inc (LMAT) Institutional Confidence

LeMaitre Vascular Inc (LMAT) has an institutional shareholding score of 10.00, placing it first in the Healthcare Equipment & Supplies industry. This score reflects a quarter-over-quarter increase of 8.41% in institutional shareholding proportion, which currently stands at 102.98%. ETHSX is the largest institutional shareholder, …

Shareholders of Microvast Holdings, Inc. (MVST): Protect Your Rights Before September 21, 2026 - Contact Levi & Korsinsky

Levi & Korsinsky, LLP has filed a securities class action lawsuit against Microvast Holdings, Inc. (NASDAQ:MVST) on behalf of investors who suffered losses due to alleged securities fraud between April 1, 2025, and March 16, 2026. The lawsuit claims Microvast made false statements regarding …

LeMaitre Vascular Inc (LMAT) Financial Health: Profitability & Balance Sheet Analysis

LeMaitre Vascular Inc (LMAT) has a robust financial status with a current financial score of 9.04, ranking 11th in the Healthcare Equipment & Supplies industry. The company demonstrated high operating efficiency with a 11.16% year-over-year increase in quarterly revenue to $66.55M and a 42.39% …

Class Action Lawsuit Announced for Microvast Securities

Rosen Law Firm has initiated a class action lawsuit against Microvast Holdings, Inc. (NASDAQ:MVST) on behalf of investors who purchased securities between April 1, 2025, and March 16, 2026. The lawsuit alleges that Microvast made false and misleading statements regarding inventory management and commercial …

LeMaitre Vascular (LMAT) insider Bridget Ross files to sell 4,322 shares

LeMaitre Vascular insider Bridget A. Ross has filed to sell 4,322 shares of common stock, valued at $449,241.48, through a Form 144. The sale is expected on July 29, 2026, and relates to a stock option exercise. Ross previously sold 5,044 shares for $560,366.40 …

MVST UPCOMING DEADLINE: Levi & Korsinsky Alerts Microvast Holdings, Inc. Stockholders of Securities Class Action - Contact the Firm

Levi & Korsinsky, LLP has filed a securities class action lawsuit against Microvast Holdings, Inc. (NASDAQ: MVST) on behalf of investors who purchased securities between April 1, 2025, and March 16, 2026. The lawsuit alleges that Microvast made misleading statements regarding its financial projections, …

Law Offices of Howard G. Smith Encourages Microvast Holdings, Inc. (MVST) Shareholders To Inquire About Securities Fraud Class Action

The Law Offices of Howard G. Smith are encouraging Microvast Holdings, Inc. (MVST) shareholders who suffered losses between April 1, 2025, and March 16, 2026, to inquire about a securities fraud class action lawsuit. The lawsuit alleges that Microvast made misleading statements regarding its …